TransCode Therapeutics, Inc. (RNAZ) Options Chain

The options chain displays all available contracts with end-of-day quotes, Greeks, volume, and open interest for each strike and expiration, and streams live quotes for traders who connect a broker. It is the primary tool for options trade selection.

TransCode Therapeutics, Inc. (RNAZ) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $2.3M, listed on NASDAQ, employing roughly 12 people, carrying a beta of 1.24 to the broader market. TransCode Therapeutics, Inc. Led by Philippe Calais, public since 2021-07-08.

The options chain displays all available contracts with quotes, Greeks, and open interest. No recent options activity for RNAZ as of 2026-08-31; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how the options chain is reported and how to read the data →